SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today announced the release of a new range of high performance liquid chromatography (HPLC) columns ideally suited for ...
SANTA CLARA, Calif. - Agilent Technologies Inc. (NYSE:A), a $35 billion market cap company with a "GOOD" financial health rating according to InvestingPro, has released a new line of high performance ...
Agilent Technologies, Inc. has launched the ZORBAX Eclipse Plus line of HPLC columns, designed to deliver the resolution and separation of the challenging and critical basic compounds. "This a major ...
The ZORBAX Eclipse AAA high efficiency HPLC column rapidly separates amino acids following an updated and improved protocol for use with the Agilent 1100 HPLC. Total analysis from injection to ...
The Hi-Plex HPLC columns deliver improved efficiency, lower operating pressures and longer column lifetimes from monodispersed materials. With a range of ligand counter ions for optimum selectivity, ...
Agilent Technologies, Inc. has introduced new columns in both the small-molecule ultra-high performance liquid chromatography and biopharma (large molecule) categories. The AdvanceBio Glycan Mapping ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of three InfinityLab Bio LC systems specifically developed to meet the needs of the biopharma ...
Analysts interested in organic molecules like dissolved organic matter or pharmaceuticals should consider quantifying organic molecules with the High Performance Liquid Chromatography (HPLC) ...
Agilent Technologies Inc., a global leader in analytical and clinical laboratory technologies, announced the release of a new range of high performance liquid chromatography (HPLC) columns ideally ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results